Katherine Bach Kalin, Director at SELLAS Life Sciences Group, Inc. (SLS), bought 20,000 shares at $1.80 ($36K) on 2025-05-22, disclosed to the SEC on 2025-05-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.